GPCR (Structure Corp) Wutah bathi ing taun lumaku
Structure Therapeutics is actively recruiting leading endocrinologists, retaining staff through generous stock options. The company is developing oral diabetes treatments, aiming to replace injections with convenient pills. Its technologies rely on AI modeling for molecular design. By comparing the annual percentage dynamics of earnings per share on GURU.Markets, we see that the value of -111.00 expresses the metric level.
Rincian metrik keuangan lan pasar Structure Therapeutics (GPCR)
- rega saham lan prakiraan rega para ahli:
- indikator valuasi pasar bisnis:
- data kapitalisasi buku:
- indikator beban utang lan likuiditas:
Utang marang Ekuitas Structure Therapeutics|GPCR - Utang jangka dawa marang modal|Koefisien utang jangka cendhak marang modal structuretx.com|GPCR - Utang perusahaan|Utang-utang marang aset resik Structure Corp|GPCR - Utang jangka dawa perusahaan|Kewajiban jangka cendhak perusahaan Structure Therapeutics|Koefisien jangkoan perantara structuretx.com
- informasi bathi lan kelipatan valuasi:
GPCR - Penghasilan resik|Bathi resik mangsa ngarep Structure Therapeutics|GPCR - Rasio rega marang bathi|Pangali mangsa ngarep rega marang bathi Structure Corp|GPCR - Pangali rega marang bathi tumrap wutah|Pangali EV/EBITDA Structure Corp|GPCR - Bathi operasional EBITDA|Bathi resik saben saham sajrone 12 wulan pungkasan Structure Therapeutics|GPCR - Bathi resik saben saham sajrone 12 wulan pungkasan|Kacepetan wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan structuretx.com|GPCR - Wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi kanggo taun ngarep Structure Therapeutics
Analisis dhasar perusahaan:GPCR - Structure Therapeutics Inc
Challenges with international research and raw material logistics for metabolic drugs are directly reflected in the profit dynamics of Structure Therapeutics (GPCR). The current year-over-year EPS percentage deviation of -111.00 measures the rate of change in net income per share, allowing investors to assess the efficiency of the company's operating model amid geopolitical barriers and currency fluctuations.
Pesaing utama
ASND: Wutah bathi resik saben siji saham kanggo taun lumaku|MDGL (Madrigal Pharma) - Wutah bathi ing taun lumaku|Wutah bathi ing taun lumaku Corcept Therapeutics Corp|Wutah bathi ing taun lumaku RYTM|Wutah bathi saben saham ing taun lumaku AKRO (akerotx.com)|Wutah bathi saben saham ing taun lumaku Metsera MTSR|MoonLake Immunotherapeutics AG (MLTX) - Kacepetan wutah bathi saben saham ing taun lumaku|CRNX - Wutah bathi saben saham ing taun lumaku|NAMS: Wutah bathi saben saham ing taun lumaku|SLNO: Wutah bathi ing taun lumaku|FOLD - Prakiraan wutah bathi resik saben saham ing taun iki|Wutah bathi saben saham ing taun lumaku 89bio|Agios (AGIO) - Prakiraan wutah bathi resik saben saham ing taun iki|Wutah bathi saben saham ing taun lumaku MiMedx Group (MDXG)|Wutah bathi resik saben saham ing taun iki Rezolute Bio RZLT|Wutah bathi saben saham ing taun lumaku Lexicon Pharmaceuticals LXRX|Prakiraan wutah bathi resik saben saham ing taun iki mbxbio.com (MBX)|ALT: Wutah bathi resik saben saham ing taun iki|Aardvark Therapeutics Inc. - Wutah bathi resik saben siji saham kanggo taun lumaku|Sagimet (SGMT) - Wutah bathi saben saham ing taun lumaku|BioAge Labs, Inc - Tambahing bathi saben saham ing taun lumaku|Wutah bathi resik saben saham ing taun iki BMEA|Wutah bathi ing taun lumaku Quince|Wutah bathi ing taun lumaku GUTS|Wutah bathi resik saben saham ing taun iki vtvtherapeutics.com VTVT|Agape ATP - Wutah bathi resik saben saham ing taun iki|Wutah bathi resik saben siji saham kanggo taun lumaku PLUR (Pluristem Therapeutics)|SYBX: Wutah bathi resik saben saham ing taun iki|LPCN - Wutah bathi ing taun lumaku|matinasbiopharma.com (MTNB) - Wutah bathi saben saham ing taun lumaku|sprucebiosciences.com - Tambahing bathi saben saham ing taun lumaku|GLTO (Galecto Corp) - Wutah bathi ing taun lumaku|Kacepetan wutah bathi saben saham ing taun lumaku Carmell Therapeutics CTCX|Wutah bathi resik saben saham ing taun iki LUMO (Lumos Pharma, Inc.)|ONVO (organovo.com) - Tambahing bathi saben saham ing taun lumaku|Radius Recycling - Wutah bathi resik saben saham ing taun iki
